Aarti Drugs share news, announcements and annual reports
NSE: AARTIDRUGSBSE: 524348Pharmaceuticals & BiotechnologySmall Cap
Aarti Drugs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1993 on BSE, Sep 2003 on NSE
Last close ₹435.20down ₹13.80 (3.07%)BSE ₹435.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹449.00.
30 Oct: open ₹444.00, high ₹449.00, low ₹432.50
52-week range of traded prices to 30 Oct 2026
₹318.95Low, 30 Mar 2026₹534.00High, 10 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,972 Cr930th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.46%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.37
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,91,56330.3% delivered
Aarti Drugs board meetings
113 filed, newest first. Page 2 of 3.
Oct 2018
25 Oct · Board meeting
Aug 2018
6 Aug · Board meeting
May 2018
Feb 2018
Jan 2018
8 Jan · Board meeting
Nov 2017
Aug 2017
May 2017
Jan 2017
Oct 2016
Aug 2016
Apr 2016
Mar 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
Mar 2015
17 Mar · Board meeting
To consider and approve the allotment of 121,08,550 Equity shares as Bonus issue in the proportion of 1 (One) new equity share for every 1 (One) existing fully paid equity shares as approved by the shareholders through postal ballot on March 13, 2015.
Jan 2015
30 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 30, 2015, has inter alia approved the following subject to necessary approvals of Company's shareholders which would be obtained through Postal Ballot & E-Voting: 1. Increase of Authorized Share Capital & consequent alteration of Memorandum of Association: Authorized Share Capital of the Company will be increased from Rs. 21,50,00,000 to Rs. 25,00,00,000 and consequent alteration of Clause V of Memorandum of Association of the Company.19 Jan · Board meeting
Inter-alia to : (1) Consider, approve and take on record audited financial results and accounts for the quarter and nine month ended on December 31, 2014. (2) Consider declaration of 2nd Interim Dividend, if any.
Nov 2014
3 Nov · Board meeting
Inter-alia to: 1. Consider, approve and take on record audited financial results and accounts for the quarter and half year ended on September 30, 2014. 2. Consider declaration of Interim dividend, if any.
Jul 2014
Apr 2014
Jan 2014
Oct 2013
30 Oct · Board meeting
Inter-alia to : (1) Consider, approve and take on record audited financial results and accounts for the quarter and half year ended on September 30, 2013; (2) Consider declaration of Interim Dividend, if any.
Jul 2013
23 Jul · Board meeting
To consider, approve and take on record the Audited Financial Results and Accounts for the quarter ended 30th June, 2013.
May 2013
Jan 2013
23 Jan · Board meeting
Inter -alia to: (1) Consider, approve and to take on record audited financial results and accounts for the quarter and nine months ended December 31, 2012. (2) Consider declaration of 2nd Interim Dividend, if any.
Oct 2012
19 Oct · Board meeting
Inter-alia to : (1) Consider, approve and take on record audited financial results and accounts for the quarter and half year ended on September 30, 2012; (2) Consider declaration of Interim Dividend, if any.
Jul 2012
30 Jul · Board meeting
Inter-alia, to consider, approve and take on record the audited financial results and accounts for the quarter ended June 30, 2012.
Jun 2012
26 Jun · Board meeting
Inter-alia to: (1) Reconsider, approve and take on record the Audited Financial Results for the year ended March 31, 2012, post amalgamation of Suyash Laboratories Limited (Wholly-owned subsidiary of the Company) with the Company approved by the Bombay High Court on May 11, 2012, to be effective from April 01, 2011.
May 2012
11 May · Board meeting
Inter-alia to: 1) consider, approve and take on record the audited financial results and accounts for the quarter and year ended on March 31, 2012. 2) Consider declaration of final Dividend, if any.
Feb 2012
3 Feb · Board meeting
Shri Chandrakant V. Gogri, Founder Chairman of the Company has indicated to retire as the Chairman & Director of the Company upon attaining age of 66 years on August 16, 2012. In view of the above, a meeting of the Board of Directors of the Company will be held on February 09, 2012, to consider and approve succession plan.
Jan 2012
23 Jan · Board meeting
Inter -alia to: (1) Consider , approve and to take on record audited financial results and accounts for the quarter and nine months ended December 31, 2011. (2) Consider declaration of interim Dividend , if any.
Nov 2011
2 Nov · Board meeting
Inter-alia, to consider, approve and take on record the audited financial results and accounts for the quarter and half year ended September 30, 2011.
Jul 2011
20 Jul · Board meeting
Inter alia, to consider, approve and take on record the audited financial results and accounts for the quarter ended June 30, 2011.
May 2011
16 May · Board meeting
Inter-alia to: 1) consider, approve and take on record the audited financial results and accounts for the quarter and year ended on March 31, 2011. 2) Consider declaration of final Dividend, if any.
Jan 2011
19 Jan · Board meeting
Inter-alia to: 1) consider, approve and take on record the audited financial results and accounts for the quarter ended December 31, 2010. 2) Consider declaration of Interim Dividend, if any.
Oct 2010
15 Oct · Board meeting
To consider, approve and take on record the audited financial results and accounts for the quarter & half year ended on September 30, 2010.
Jul 2010
28 Jul · Board meeting
Inter-alia, to consider, approve and take on record the audited financial results and accounts for the quarter ended June 30, 2010.
May 2010
14 May · Board meeting
Interalia, to consider, approve and take on record the audited financial results and accounts for the quarter & year ended March 31, 2010 and to consider recommendation of dividend, if any.
Jan 2010
14 Jan · Board meeting
To consider, approve and take on record the audited financial results and accounts for the quarter & nine months ended December 31, 2009.
Oct 2009
20 Oct · Board meeting
To consider, approve and take on record the audited financial results for the quarter & half year ended on September 30, 2009.
Jul 2009
17 Jul · Board meeting
To consider, approve and take on record the audited financial results and accounts for the quarter ended June 30, 2009.